Dr. Roberto Adachi, MD

Dr. Adachi practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Adachi's NPI, 1598879678, was assigned on August 18, 2006. Dr. Adachi graduated from Cayetano Heredia University in 1990. Dr. Adachi's Texas license number on file is J8857.

Dr. Adachi's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Adachi's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adachi practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Adachi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Adachi is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Adachi's licenses on file in 11 states: Texas, Florida, Arizona, Georgia, Tennessee, Washington, Louisiana, Alabama, Mississippi, Oklahoma and Michigan.

Dmand AI lists chronic obstructive pulmonary disease (COPD), pleural effusion, pneumonia and pulmonary fibrosis among the conditions Dr. Adachi treats.

CMS data shows 1,195 Medicare services from Dr. Adachi across 11 procedure codes in 2024, for 451 Medicare patients. Medicare paid $29,553 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 451 Medicare patients who saw Dr. Adachi in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adachi's median patient age at 69, with 57% women.

In 2024, Dr. Adachi wrote 105 Medicare Part D claims for 31 patients. 13% of them were for generic drugs. CMS names the drug for 83 of them, across 2 drugs with 11 or more claims each, at $43,671 in total drug cost. In 2023, CMS named 127 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Adachi for performance year 2024, reported as part of a group. Dr. Adachi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Adachi, published from 2005 to 2021. 2009 was the busiest year, with 3. The most frequent topics are Mast Cells, Mice, Knockout and Exocytosis. Dr. Adachi has published most often in J Biol Chem. Dr. Adachi's most frequent co-authors are Burton F. Dickey, MD, Rolando Enrique Rumbaut, MD, PhD and Niloufar Aghakasiri, MD.

Dr. Adachi graduated from Cayetano Heredia University in 1990.

Dr. Adachi is in network with 4 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.